Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji.
HENDERSON, AD; Aubry, M; Kama, M; Vanhomwegen, J; Teissier, A; Mariteragi-Helle, T; Paoaafaite, T; Teissier, Y; Manuguerra, J-C; EDMUNDS, J; WHITWORTH, J; Watson, CH; Lau, CL; Cao-Lormeau, V-M; KUCHARSKI, AJ;
2020
ELIFE, (2020).9, 10.7554/eLife.48460.
Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti.
VAN DEN HOOGEN, LL; Présumé, J; Romilus, I; Mondélus, G; Elismé, T; Sepúlveda, N; STRESMAN, G; Druetz, T; Ashton, RA; Joseph, V; Eisele, TP; Hamre, KE S; Chang, MA; Lemoine, JF; TETTEH, KK A; Boncy, J; Existe, A; DRAKELEY, C; Rogier, E;
2020
Scientific reports, (2020).10 1 10.1038/s41598-020-57876-0.
Choosing a Mass Immunization Program against Meningococcal B.
Wu, K; MULHOLLAND, EK; Edwards, KM;
2020
NEW ENGLAND JOURNAL OF MEDICINE, (2020).382 4 10.1056/NEJMclde1916746.
Administer the Meningococcal B Vaccine to All 17-to-18-Year-Olds and to All Students at Universities with an Outbreak.
MULHOLLAND, EK;
2020
NEW ENGLAND JOURNAL OF MEDICINE, (2020).382 4
The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study.
Portnoy, A; Clark, S; Ozawa, S; JIT, M;
2020
International journal for equity in health, (2020).19 1 10.1186/s12939-019-1090-3.
State of vaccine confidence in the EU + UK 2020.
DE FIGUEIREDO, C; KARAFILLAKIS, E; LARSON, H;
2020
, European Commission (Luxembourg) (2020). 10.2875/06196.
Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan.
ANWARI, P; Debellut, F; Vodicka, E; CLARK, A; Farewar, F; Zhwak, ZA; Nazary, D; Pecenka, C; Scott LaMontagne, D; Safi, N;
2019
Vaccine, (2019).38 6 10.1016/j.vaccine.2019.12.013.
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials.
WHITWORTH, HS; GALLAGHER, KE; HOWARD, N; MOUNIER-JACK, S; Mbwanji, G; Kreimer, AR; Basu, P; KELLY, H; Drolet, M; Brisson, M; WATSON-JONES, D;
2019
Vaccine, (2019).38 6 10.1016/j.vaccine.2019.12.017.
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis.
Levillain, F; Kim, H; Woong Kwon, K; Clark, S; Cia, F; Malaga, W; Lanni, F; Brodin, P; Gicquel, B; Guilhot, C; BANCROFT, GJ; Williams, A; Jae Shin, S; Poquet, Y; Neyrolles, O;
2019
Vaccine, (2019).38 6 10.1016/j.vaccine.2019.11.085.
Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?.
Pecenka, C; Debellut, F; Bar-Zeev, N; ANWARI, P; Nonvignon, J; CLARK, A;
2019
Vaccine, (2019).38 6 10.1016/j.vaccine.2019.12.014.